SCHEMBL17362228

SCHEMBL17362228

CC(C)(C)Nc1ncc(-c2cccc(-c3ccccc3)c2F)cc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCN9A Q15858 2/20 0.46
▸ ALOX5AP P20292 3/20 0.40
▸ FEN1 P39748 3/20 0.40
▸ PRKD3 O94806 1/20 0.40
▸ MAP4K4 O95819 1/20 0.40
▸ PAK4 O96013 1/20 0.40
▸ NTRK1 P04629 1/20 0.40
▸ PRKACA P17612 1/20 0.40
▸ LTK P29376 1/20 0.40
▸ MAP2K2 P36507 1/20 0.40
▸ MAPK8 P45983 1/20 0.40
▸ CDK8 P49336 1/20 0.40
▸ CLK2 P49760 1/20 0.40
▸ GSK3A P49840 1/20 0.40
▸ GSK3B P49841 1/20 0.40
▸ RPS6KA3 P51812 1/20 0.40
▸ CDK5 Q00535 1/20 0.40
▸ MAP2K1 Q02750 1/20 0.40
▸ PRKCQ Q04759 1/20 0.40
▸ MST1R Q04912 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17362247 0.87 PRKD3 (0.41) SCN9AALOX5APFEN1PRKD3MAP4K4
SCHEMBL17362342 0.85 PRKD3 (0.42) ALOX5APFEN1PRKD3MAP4K4PAK4
SCHEMBL15915342 0.84 ALOX5AP (0.43) SCN9AALOX5APFEN1PRKD3MAP4K4
SCHEMBL17362185 0.81 ALOX5AP (0.42) SCN9AALOX5APFEN1PRKD3MAP4K4
SCHEMBL17362110 0.80 PDCD1 (0.40) ALOX5APFEN1PRKD3MAP4K4PAK4
SCHEMBL17362410 0.76 ALOX5AP (0.40) ALOX5APFEN1PRKD3MAP4K4PAK4
SCHEMBL17362334 0.75 ALOX5AP (0.39) ALOX5APFEN1PRKD3MAP4K4PAK4
SCHEMBL17362411 0.75 ALOX5AP (0.45) ALOX5APFEN1PRKD3MAP4K4PAK4
SCHEMBL15917307 0.73 CD274 (0.47) ALOX5APFEN1CCNE2CCNE1CDK2
SCHEMBL17362293 0.72 ALOX5AP (0.42) ALOX5APFEN1PRKD3MAP4K4PAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9745328-B2 Flap modulators JANSSEN PHARMACEUTICA NV (BE) 2017-08-29 — — US disclosed
US-20150376212-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2015-12-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150376212-A1 FLAP MODULATORS FEN1, PGF, TBXA2R SCN9A 4784/4885ALOX5AP 95/4885FEN1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback